Daré Bioscience, Inc. (DARE)
0.8015
-0.02
(-2.24%)
USD |
NASDAQ |
Aug 24, 16:00
0.8277
+0.03
(+3.27%)
After-Hours: 07:39
Daré Bioscience Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 29, 2026 | 41.67 |
| June 26, 2026 | 41.47 |
| June 25, 2026 | 39.68 |
| June 24, 2026 | 41.27 |
| June 23, 2026 | 41.07 |
| June 22, 2026 | 40.67 |
| June 18, 2026 | 43.06 |
| June 17, 2026 | 41.27 |
| June 16, 2026 | 41.86 |
| June 15, 2026 | 39.29 |
| June 12, 2026 | 40.08 |
| June 11, 2026 | 40.28 |
| June 10, 2026 | 39.68 |
| June 09, 2026 | 38.10 |
| June 08, 2026 | 36.71 |
| June 05, 2026 | 37.30 |
| June 04, 2026 | 43.25 |
| June 03, 2026 | 40.67 |
| June 02, 2026 | 42.46 |
| June 01, 2026 | 43.45 |
| May 29, 2026 | 44.25 |
| May 28, 2026 | 45.24 |
| May 27, 2026 | 46.23 |
| May 26, 2026 | 46.43 |
| May 22, 2026 | 47.02 |
| Date | Value |
|---|---|
| May 21, 2026 | 47.82 |
| May 20, 2026 | 46.23 |
| May 19, 2026 | 44.64 |
| May 18, 2026 | 41.86 |
| May 15, 2026 | 43.06 |
| May 14, 2026 | 56.75 |
| May 13, 2026 | 56.35 |
| May 12, 2026 | 52.18 |
| May 11, 2026 | 50.00 |
| May 08, 2026 | 54.56 |
| May 07, 2026 | 57.74 |
| May 06, 2026 | 62.70 |
| May 05, 2026 | 64.88 |
| May 04, 2026 | 61.71 |
| May 01, 2026 | 46.43 |
| April 30, 2026 | 45.24 |
| April 29, 2026 | 41.67 |
| April 28, 2026 | 43.45 |
| April 27, 2026 | 44.44 |
| April 24, 2026 | 41.86 |
| April 23, 2026 | 42.06 |
| April 22, 2026 | 45.04 |
| April 21, 2026 | 46.83 |
| April 20, 2026 | 56.94 |
| April 17, 2026 | 58.53 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Nektar Therapeutics | 2.785 |
| Elite Pharmaceuticals, Inc. | 2.971 |
| Eton Pharmaceuticals, Inc. | 39.13 |
| ANI Pharmaceuticals, Inc. | 2.853 |
| Corcept Therapeutics, Inc. | 18.84 |
Price to Book Value Related Metrics
| PS Ratio | 8.313 |
| Price | 0.8015 |
| Earnings Yield | -98.02% |
| Market Cap | 12.16M |